Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

NCT03836690 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03836690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03836690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
Lead sponsor
University College, London
Phase
Phase 1
Overall status
Unknown status
Start date
October 21, 2019
Completion date
April 1, 2023
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, leukemia, lymphoma, myelodysplastic syndromes, myeloma, primary immune deficiency, severe aplastic anemia